Figure 1
![Figure 1. KL dose-response in β thalassemic patients. Cell growth (top panels) and HbF content (bottom panels) in minibulk HPC unilineage erythroid cultures derived from a representative β-TI (left panels) and β-TM patient (right panels), supplemented or not with graded amounts of KL (1, 10, or 100 ng/mL). The total cell number is shown in top panels. The percentage of HbF content (evaluated as the γ/[β + γ] and γ/α ratio in β-TI and β-TM, respectively) is reported in bottom panels.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/111/1/10.1182_blood-2007-06-097550/3/zh80040812900001.jpeg?Expires=1722722409&Signature=n3P~360KZdC7dGUiB0JkSgJEcuGnnbc69dszH3J5rvvFEaXE3~tf861iqUNLVMwRvrqc4ThhUC39BPaxvJ6UrnSO8WQo5jPloZHbIHGYqZC4VnzGpS8tBq-x-FprQns~vunKeTxMnOST7D0rSxwxg883OaPsuI2K1a~WenKf7T6GDdsyiTaObr40-M18tvIFEna4W~gTXQN~~o8VK3jTuWx23YYGh-BGJQQaviVlM9IIZbFkS0rMYdzIW2I8NcoPetXWeHuZh~0RLCn~19llxdnwXkUq3Sg-JL64hYqHQ2Nf561Drug6avPZ3nIbmynmVM15~Vh-MrXrzcpSK~Guzw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
KL dose-response in β thalassemic patients. Cell growth (top panels) and HbF content (bottom panels) in minibulk HPC unilineage erythroid cultures derived from a representative β-TI (left panels) and β-TM patient (right panels), supplemented or not with graded amounts of KL (1, 10, or 100 ng/mL). The total cell number is shown in top panels. The percentage of HbF content (evaluated as the γ/[β + γ] and γ/α ratio in β-TI and β-TM, respectively) is reported in bottom panels.
